Data from a 3-year extension of the LiGHT trial show that selective laser trabeculoplasty provides better long-term disease control than initial drop therapy. Selective laser trabeculoplasty (SLT) has been approved to treat glaucoma since 2001, but...
![PW-Circle-Logo-lockup_Horizontal](https://cdn.physiciansweekly.com/wp-content/uploads/2024/02/PW-Circle-Logo-lockup_Horizontal.webp)